Corrigendum to Contractility defects hinder glycoprotein VI-mediated platelet activation and affect platelet functions beyond clot contraction [Research and Practice in Thrombosis and Haemostasis Volume 8, Issue 1, January 2024, 102322]
Year: 2024
Type: erratum
Abstract: The authors regret that the source for Glenzocimab was not acknowledged in the article. Glenzocimab was kindly provided under a material transfer agreement by Acticor Biotech SA. The authors would like to apologise for any inconvenience caused. Contractility defects hinder glycoprotein VI-mediated platelet activation and affect platelet functions beyond clot contractionResearch and Practice in Thrombosis and HaemostasisVol. 8Issue 1PreviewActive and passive biomechanical properties of platelets contribute substantially to thrombus formation. Actomyosin contractility drives clot contraction required for stabilizing the hemostatic plug. Impaired contractility results in bleeding but is difficult to detect using platelet function tests. Full-Text PDF Open Access
Authors: Martin Kenny, Alice Y. Pollitt, Smita Patil, Dishon W. Hiebner, Albert Smolenski, Natalija Lakic, Robert Fisher, Reema Alsufyani, Sebastian Lickert, Viola Vogel, Ingmar Schoen
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,250
OpenAlex ID: W4395002960